Effect of an Intensive Chemotherapy Followed by Mediastinal Irradiation on Pulmonary and Cardiac Function in Advanced Hodgkin's Disease

References

• Cionini L., Pacini P., De Paola E., et al. Respiratory function tests after mantle irradiation in patients with Hodgkin's disease. Acta Radiol. 1984; 23: 401–409
   Web of Science ®Google Scholar
• Smith L.M., Mendenhall N.P., Cicale M.J., et al. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int. J. Radiat. Oncol. Biol. Phys. 1988; 16: 79–84
   Web of Science ®Google Scholar
• Tarbell N.J., Thompson L., Mauch P. Thoracic irradiation in Hodgkin's disease: Disease control and long-term complications. Int. J. Radiat. Oncol. Biol. Phys. 1990; 18: 2705–2781
   Google Scholar
• Movses B., Raffin T.A., Epstein A.M., et al. Pulmonary radiation injury. Chest 1997; 111: 1061–1076
   PubMed Web of Science ®Google Scholar
• Watchie J., Norman Coleman C., Raffin T.A., et al. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 1987; 13: 517–524
   PubMed Web of Science ®Google Scholar
• Hassink E.A.M., Souren T.S., Boersma L.J., et al. Pulmonary morbidity 10–18 years after irradiation for Hodgkin's desease. Eur. J. Cancer 1993; 29A: 343–347
   PubMed Web of Science ®Google Scholar
• Morgan G., Freeman A., McLean R.G., et al. Late cardiac, thyroid and pulmonary sequelæ of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 1925–1931
   PubMed Web of Science ®Google Scholar
• Villani F., De Maria P., Bonfante V., et al. Late pulmonary toxicity after treatment for Hodgkin's disease. Anticancer Res. 1997; 7: 4739–4742
   Google Scholar
• Roberts C.M., Foulcher E., Zaunders J.J., et al. Radiation pneumonitis. A possible lymphocyte-mediated hypersensitivity reaction. Ann. Intern. Med. 1993; 113: 696–700
   Google Scholar
• Cosset J.M., Henry Amar H., Thomas J., et al. Increased pulmonary toxicity in the ABVD arm of the EORTC H6V Trial. J. Clin. Oncol. 1989; 8A: 985
   Google Scholar
• Green D.M., Gingell R.L., Pearce J., et al. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J. Clin. Oncol. 1987; 5: 239–245
   PubMed Web of Science ®Google Scholar
• Kadota R.P., Burgett O., Driscoll D. Cardiopulmonary function in long-term survivors of childhood Hodgkin's lymphoma. Mayo Clin. Proc. 1988; 63: 362–367
   PubMed Web of Science ®Google Scholar
• Mefferd J.M., Donaldson S.S., Link M.P. Pediatric Hodgkin's disease: pulmonary cardiac and thyroid function following combined modality therapy. Int. J. Radiat. Oncol. Biol. Phys. 1989; 16: 679–685
   PubMed Web of Science ®Google Scholar
• Hancock S.L., Tucker M.A., Hoper R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. J. Am. Med. Assoc. A 1993; 270: 1949–1955
   PubMed Web of Science ®Google Scholar
• Morgan G.W., Freeman A.P., McLean R.G., et al. Late cardiac, thyroid, and pulmonary sequelæ of mantle radiotherapy for Hodgkin's disease. Int. J. Radiat. Oncol. Biol. Phys. 1985; 11: 1925–1931
   PubMed Web of Science ®Google Scholar
• Gottdiener J.S., Katin M.J., Borer J.S., et al. Late cardiac effect of therapeutic mediastinal irradiation. N. Engl. J. Med. 1983; 308: 569–571
   PubMed Web of Science ®Google Scholar
• Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin. Oncol. 1992; 5: 529–542
   Google Scholar
• Lamonte C.S., Yeh S.D.J., Straus D.J. Long term follow up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin. Cancer Treat. Rep. 1986; 70: 439–444
   PubMedGoogle Scholar
• Ogilvie C.M., Forster R.E., Blakemore W.S., et al. A standardized breath-holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J. Clin. Investig. 1957; 36: 1–17
   PubMed Web of Science ®Google Scholar
• Cotes J.E. Measurement of the transfer factor (diffusing capacity) for the lung and its subdivision. Lung Function. 4th Ed.;, Blackwell Scientific Publications, Boston 1979; 230–250
   Google Scholar
• Dinakara P., Blumenthal W.S., Johnston R.F., et al. The effect of anæmia on pulmonary diffusing capacity with derivation of a correct equation. Am. Rev. Respir. Dis. 1970; 102: 965–969
   PubMed Web of Science ®Google Scholar
• Roughton F.J.W., Forster R.E. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries. J. Appl. Physiol. 1951; 2: 290–302
   Google Scholar
• Pavel D.G., Zimmer A.M., Patterson V.N. In vivo labelling of red blood cells with Tc-99 m: a new approach to blood visualization. J. Nucl. Med. 1977; 18: 305–308
   PubMed Web of Science ®Google Scholar
• Alexander J.A., Dainiak N., Berger H.J. Serial assessment of doxorubicin cardiotoxcity with quantitative radionuclide angiocardiography. N. Eng. J. Med. 1979; 300: 278–283
   PubMed Web of Science ®Google Scholar
• Dopico G.A., Wiley A.L., Rao P., et al. Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest 1979; 75: 688–692
   PubMed Web of Science ®Google Scholar
• Santoro A., Bonadonna G., Valagussa P., et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J. Clin. Oncol. 1987; 5: 27–37
   PubMed Web of Science ®Google Scholar
• Brice P., Tredaniel J., Monsuez J.J., et al. Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favourable Hodgkin's disease. Ann. Oncol. 1991; 2: 73–76
   PubMed Web of Science ®Google Scholar
• Hirsch A., Vander Els N., Strauss D.J., et al. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early stage Hodgkin's disease. J. Clin. Oncol. 1996; 14: 1297–1305
   PubMed Web of Science ®Google Scholar
• Bossi G., Cerveri L., Volpini E., et al. Long-term pulmonary sequelæ after treatment of childhood Hodgkin's disease. Ann. Oncol. 1997; 8: 19–24
   PubMed Web of Science ®Google Scholar
• Villani F., Dell'Oca I., De Maria P., et al. Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and Fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's disease. Anticancer Res. 1999; 19: 4475–4480
   PubMed Web of Science ®Google Scholar
• Von Hoff D.D., Layrd M.V., Basa P., et al. Risk factors for doxorubicin induced congestive heart failure. Ann. Intern. Med. 1979; 91: 710–717
   PubMed Web of Science ®Google Scholar
• Shan L., Lincoff M., Young J.B. Anthracycline-induced cardiotoxicity. Ann. Intern. Med. 1996; 125: 47–58
   PubMed Web of Science ®Google Scholar
• Nielsen D., Jensen J.B., Dombernowsky P., et al. Epirubicin cardiotoxicity: a study of 135 patients with advanced breast cancer. J. Clin. Oncol. 1990; 8: 1806–1810
   PubMed Web of Science ®Google Scholar
• Lahtinen R., Kuikka J., Nousiainen T., et al. Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study. Eur. J. Haematol. 1991; 46: 301–305
   PubMed Web of Science ®Google Scholar
• Goldberg M.A., Antin J.H., Guinan E.C., et al. Cyclophosphamide cardiotoxicity: an analysis of dosing and risk factor. Blood 1986; 68: 1114–1118
   PubMed Web of Science ®Google Scholar
• McEnjery P.T., Dorostic K., Schiavone W.A., et al. Clinical angiographic feature of coronary artery disease after chest irradiation. Am. J. Cardiol. 1987; 60: 1021–1024
   Google Scholar
• Corn B.W., Trock B.J., Goodman R.L. Irradiation related ischemic heart disease. J. Clin. Oncol. 1990; 8: 741–750
   PubMed Web of Science ®Google Scholar
• Boinvin J.F., Hutchison G.B., Lubin J.H., Manch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992; 69: 1241–1247
   PubMed Web of Science ®Google Scholar
• Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease on children and adolescents. J. Clin. Oncol. 1993; 11: 1208–1215
   PubMed Web of Science ®Google Scholar